Research Reports from Internal Medicine Department Provide New Insights into Respiratory Alkalosis (Respiratory alkalosis as an adverse effect of safinamide?).

Research reports from the Internal Medicine Department provide new insights into respiratory alkalosis, specifically focusing on the potential adverse effect of safinamide therapy. The study highlights a case of a 71-year-old woman with Parkinson's disease who experienced respiratory alkalosis after starting safinamide treatment, leading to multiple emergency department visits. The research suggests a pharmacological link to the respiratory alkalosis, emphasizing the importance of monitoring and managing potential side effects of medications like safinamide. [Extracted from the article]